//@saka_6:I registered with a

2023-02-03

//@saka_6:I registered with a scam broker and was tricked into putting in money, they also attempted to take money from my card without my consent. I had to hire a solution professional broker, Lily Anderson fxtrade on instag or Facebook to help me recover my money, be careful do not take any Bonus offer from your broker or your manager. I think she is one of the best account manager when it comes to trade, invest as much as you can with her you'll be glad.

Merck Forecasts Sharp Drop in COVID Antiviral Pill Sales in 2023

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Derrick_1234
2023-02-03
Derrick_1234
Ok
StarryEyes
2023-02-03
StarryEyes
K
jjshlq
2023-02-03
jjshlq
🥸
AloysiusChan
2023-02-03
AloysiusChan
Ok
lhc12000
2023-02-03
lhc12000
ok
Huinan
2023-02-03
Huinan
T

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":9955601401,"tweetId":"9955601401","gmtCreate":1675377709703,"gmtModify":1676538997159,"author":{"id":4118609716965282,"idStr":"4118609716965282","authorId":4118609716965282,"authorIdStr":"4118609716965282","name":"Ronronron","avatar":"https://community-static.tradeup.com/news/cf9159fc6c097ad403fe71e11c8524b3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":8,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.09.28","exceedPercentage":"60.54%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":27,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>//<a href=\"https://ttm.financial/U/4138480088946532\">@saka_6</a>:I registered with a scam broker and was tricked into putting in money, they also attempted to take money from my card without my consent. I had to hire a solution professional broker, Lily Anderson fxtrade on instag or Facebook to help me recover my money, be careful do not take any Bonus offer from your broker or your manager. I think she is one of the best account manager when it comes to trade, invest as much as you can with her you'll be glad.</body></html>","htmlText":"<html><head></head><body>//<a href=\"https://ttm.financial/U/4138480088946532\">@saka_6</a>:I registered with a scam broker and was tricked into putting in money, they also attempted to take money from my card without my consent. I had to hire a solution professional broker, Lily Anderson fxtrade on instag or Facebook to help me recover my money, be careful do not take any Bonus offer from your broker or your manager. I think she is one of the best account manager when it comes to trade, invest as much as you can with her you'll be glad.</body></html>","text":"//@saka_6:I registered with a scam broker and was tricked into putting in money, they also attempted to take money from my card without my consent. I had to hire a solution professional broker, Lily Anderson fxtrade on instag or Facebook to help me recover my money, be careful do not take any Bonus offer from your broker or your manager. I think she is one of the best account manager when it comes to trade, invest as much as you can with her you'll be glad.","highlighted":2,"essential":1,"paper":1,"likeSize":19,"commentSize":20,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/9955601401","repostId":1180524753,"repostType":4,"repost":{"id":"1180524753","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1675337653,"share":"https://www.laohu8.com/m/news/1180524753?lang=&edition=full","pubTime":"2023-02-02 19:34","market":"us","language":"en","title":"Merck Forecasts Sharp Drop in COVID Antiviral Pill Sales in 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=1180524753","media":"T-Reuters","summary":"(Reuters) - Merck & Co (MRK.N) on Thursday forecast a sharp decline in sales of its COVID-19 antivir","content":"<html><head></head><body>(Reuters) - Merck &amp; Co (MRK.N) on Thursday forecast a sharp decline in sales of its COVID-19 antiviral pill as the pandemic eases globally.The company estimated sales of molnupiravir, which is sold under the brand Lagevrio, to fall to about $1 billion this year from $5.68 billion in 2022.The lower forecast for the COVID drug is the latest signal that a boost to global drugmakers from the pandemic is fading.Roche(ROG.S) also warned on Thursday that profits will decline in 2023 due to falling demand for its COVID-19 therapy and diagnostics kits.Merck also forecast 2023 earnings below analysts&#39; estimates on a tax hit from a recent acquisition.The company said it expects adjusted earnings of $6.80 to $6.95 per share, lower than analysts&#39; average estimate of $7.36.The U.S. drugmaker&#39;s shares were down 3% in premarket trade.Revenue is projected to be $57.2 billion to $58.7 billion, compared with expectations of $58.1 billion.The earnings forecast was hit by taxes that Merck will have to pay on the $1.35 billionacquisitionof cancer drug developer Imago BioSciences, the company said.The company, however, reported higher-than-expected fourth-quarter earnings on strong sales of its COVID-19 pill in Asia.Sales in the quarter were $13.83 billion, up from $13.52 billion a year earlier. Analysts had expected sales of $13.67 billion, according to Refinitiv data.Excluding items, Merck earned $1.62 per share, exceeding Wall Street expectations of $1.54, according to Refinitiv.Sales of molnupiravir were $825 million in the quarter, compared with estimates of around $358 million.Merck Chief Executive Rob Davis said the pandemic wave that moved through Asia in the fourth quarter drove sales of molnupiravir, particularly in Japan, South Korea and other areas of the Asia Pacific region.&#34;That really was the strength, and we&#39;ve seen very good demand for Lagevrio in those markets,&#34; Davis said in an interview. &#34;In Japan, we are a market leader.&#34;The drug was not approved for use in China until Dec. 30, so sales there were not a factor in the fourth quarter.Sales of Merck&#39;s blockbuster cancer immunotherapy, Keytruda, rose 19% to $5.45 billion, largely in line with estimates.The human papillomavirus vaccine Gardasil had sales of $1.47 billion, slightly underperforming expectations.</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck Forecasts Sharp Drop in COVID Antiviral Pill Sales in 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck Forecasts Sharp Drop in COVID Antiviral Pill Sales in 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\nT-Reuters \n2023-02-02 19:34\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body>(Reuters) - Merck &amp; Co (MRK.N) on Thursday forecast a sharp decline in sales of its COVID-19 antiviral pill as the pandemic eases globally.The company estimated sales of molnupiravir, which is sold under the brand Lagevrio, to fall to about $1 billion this year from $5.68 billion in 2022.The lower forecast for the COVID drug is the latest signal that a boost to global drugmakers from the pandemic is fading.Roche(ROG.S) also warned on Thursday that profits will decline in 2023 due to falling demand for its COVID-19 therapy and diagnostics kits.Merck also forecast 2023 earnings below analysts&#39; estimates on a tax hit from a recent acquisition.The company said it expects adjusted earnings of $6.80 to $6.95 per share, lower than analysts&#39; average estimate of $7.36.The U.S. drugmaker&#39;s shares were down 3% in premarket trade.Revenue is projected to be $57.2 billion to $58.7 billion, compared with expectations of $58.1 billion.The earnings forecast was hit by taxes that Merck will have to pay on the $1.35 billionacquisitionof cancer drug developer Imago BioSciences, the company said.The company, however, reported higher-than-expected fourth-quarter earnings on strong sales of its COVID-19 pill in Asia.Sales in the quarter were $13.83 billion, up from $13.52 billion a year earlier. Analysts had expected sales of $13.67 billion, according to Refinitiv data.Excluding items, Merck earned $1.62 per share, exceeding Wall Street expectations of $1.54, according to Refinitiv.Sales of molnupiravir were $825 million in the quarter, compared with estimates of around $358 million.Merck Chief Executive Rob Davis said the pandemic wave that moved through Asia in the fourth quarter drove sales of molnupiravir, particularly in Japan, South Korea and other areas of the Asia Pacific region.&#34;That really was the strength, and we&#39;ve seen very good demand for Lagevrio in those markets,&#34; Davis said in an interview. &#34;In Japan, we are a market leader.&#34;The drug was not approved for use in China until Dec. 30, so sales there were not a factor in the fourth quarter.Sales of Merck&#39;s blockbuster cancer immunotherapy, Keytruda, rose 19% to $5.45 billion, largely in line with estimates.The human papillomavirus vaccine Gardasil had sales of $1.47 billion, slightly underperforming expectations.</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180524753","content_text":"(Reuters) - Merck & Co (MRK.N) on Thursday forecast a sharp decline in sales of its COVID-19 antiviral pill as the pandemic eases globally.The company estimated sales of molnupiravir, which is sold under the brand Lagevrio, to fall to about $1 billion this year from $5.68 billion in 2022.The lower forecast for the COVID drug is the latest signal that a boost to global drugmakers from the pandemic is fading.Roche(ROG.S) also warned on Thursday that profits will decline in 2023 due to falling demand for its COVID-19 therapy and diagnostics kits.Merck also forecast 2023 earnings below analysts' estimates on a tax hit from a recent acquisition.The company said it expects adjusted earnings of $6.80 to $6.95 per share, lower than analysts' average estimate of $7.36.The U.S. drugmaker's shares were down 3% in premarket trade.Revenue is projected to be $57.2 billion to $58.7 billion, compared with expectations of $58.1 billion.The earnings forecast was hit by taxes that Merck will have to pay on the $1.35 billionacquisitionof cancer drug developer Imago BioSciences, the company said.The company, however, reported higher-than-expected fourth-quarter earnings on strong sales of its COVID-19 pill in Asia.Sales in the quarter were $13.83 billion, up from $13.52 billion a year earlier. Analysts had expected sales of $13.67 billion, according to Refinitiv data.Excluding items, Merck earned $1.62 per share, exceeding Wall Street expectations of $1.54, according to Refinitiv.Sales of molnupiravir were $825 million in the quarter, compared with estimates of around $358 million.Merck Chief Executive Rob Davis said the pandemic wave that moved through Asia in the fourth quarter drove sales of molnupiravir, particularly in Japan, South Korea and other areas of the Asia Pacific region.\"That really was the strength, and we've seen very good demand for Lagevrio in those markets,\" Davis said in an interview. \"In Japan, we are a market leader.\"The drug was not approved for use in China until Dec. 30, so sales there were not a factor in the fourth quarter.Sales of Merck's blockbuster cancer immunotherapy, Keytruda, rose 19% to $5.45 billion, largely in line with estimates.The human papillomavirus vaccine Gardasil had sales of $1.47 billion, slightly underperforming expectations.","news_type":1},"isVote":1,"tweetType":1,"viewCount":947,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":376,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":105709593,"commentId":"105709593","gmtCreate":1675378616667,"gmtModify":1675378629678,"authorId":4128166892178982,"author":{"id":4128166892178982,"idStr":"4128166892178982","authorId":4128166892178982,"name":"Derrick_1234","avatar":"https://community-static.tradeup.com/news/2727cb4b82a9acdddc79bf5c77e507f6","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955601401,"objectIdStr":"9955601401","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Ok","text":"Ok","html":"Ok","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":105709552,"commentId":"105709552","gmtCreate":1675378493001,"gmtModify":1675378505868,"authorId":3581663636601247,"author":{"id":3581663636601247,"idStr":"3581663636601247","authorId":3581663636601247,"name":"StarryEyes","avatar":"https://static.tigerbbs.com/327a84fe00acf192cb40373b35e639e6","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.12","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955601401,"objectIdStr":"9955601401","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"K","text":"K","html":"K","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":105709546,"commentId":"105709546","gmtCreate":1675378478810,"gmtModify":1675378492251,"authorId":3581748584845938,"author":{"id":3581748584845938,"idStr":"3581748584845938","authorId":3581748584845938,"name":"jjshlq","avatar":"https://static.itradeup.com/news/4a9bc547228979cbaa5b4aedf9ce3db2","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"80.14%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955601401,"objectIdStr":"9955601401","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"🥸","text":"🥸","html":"🥸","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":105709537,"commentId":"105709537","gmtCreate":1675378460201,"gmtModify":1675378473457,"authorId":4099647546870020,"author":{"id":4099647546870020,"idStr":"4099647546870020","authorId":4099647546870020,"name":"AloysiusChan","avatar":"https://community-static.tradeup.com/news/5e952397bfb1fe640cbe7654d301cad5","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955601401,"objectIdStr":"9955601401","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Ok","text":"Ok","html":"Ok","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":105709534,"commentId":"105709534","gmtCreate":1675378457553,"gmtModify":1675378470760,"authorId":4121432317044302,"author":{"id":4121432317044302,"idStr":"4121432317044302","authorId":4121432317044302,"name":"lhc12000","avatar":"https://community-static.tradeup.com/news/c5343398a5e3a10ec5fbd2fc44adb3a1","vip":1,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955601401,"objectIdStr":"9955601401","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"ok","text":"ok","html":"ok","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":105709524,"commentId":"105709524","gmtCreate":1675378442712,"gmtModify":1675378455628,"authorId":3584172939721907,"author":{"id":3584172939721907,"idStr":"3584172939721907","authorId":3584172939721907,"name":"Huinan","avatar":"https://static.tigerbbs.com/9da5c03798340d539d9f1ef4eb52afd3","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9955601401,"objectIdStr":"9955601401","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"T","text":"T","html":"T","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/9955601401"}